Target intelligence / Profile preview

Telomerase RNA component interacting RNase (TRIR)

Target
TRIR
Molecular classification
Enzyme, Exoribonuclease
01

Overview

Telomerase RNA component interacting RNase (TRIR) is a protein-coding gene recognized for its role as an exoribonuclease that participates in the processing of the 3' end of telomerase RNA. It exhibits both 3'-5' and 5'-3' exonuclease activities, capable of cleaving all four unpaired RNA nucleotides, with higher cleavage efficiency for purine bases. TRIR is important in RNA catabolic processes, including the degradation and processing of ribosomal RNA (rRNA). It is classified molecularly as an enzyme, specifically an exoribonuclease, and has been annotated under several aliases, including C19orf43 and fSAP18. Disease associations are limited and mainly include rare conditions such as binocular vision disease and Tinea unguium. As of current knowledge, there are no established drugs targeting TRIR, and its use as a biomarker or notable safety concerns in therapeutic contexts have not been documented in available sources.

Other names
C19orf43MGC2803fSAP18TERCIRExoribonuclease TRIRfunctional spliceosome-associated protein 18My029 proteinuncharacterized protein C19orf43TRIR
02

Biological functions

rRNA catabolic processRNA phosphodiester bond hydrolysisexonucleolytic activitytelomerase RNA 3' end processing
03

Disease associations

Binocular vision diseaseTinea unguium

Beyond the preview

Go deeper on Telomerase RNA component interacting RNase (TRIR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Telomerase RNA component interacting RNase (TRIR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call